Federal grants to Gigamune, Inc.
Gigamune, Inc. in San Francisco, California received $2.5 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Cancer Treatment Research, with $1.2 million. In fiscal 2025 it was awarded $400,000.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$2.5 million
- Awards7
- Awarded in FY 2025$400,000
- Largest award$400,000
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $800,000 |
| FY 2022 | 1 | $300,000 |
| FY 2023 | 3 | $650,294 |
| FY 2024 | 1 | $300,000 |
| FY 2025 | 1 | $400,000 |
Programs that fund Gigamune, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 3 | $1.2 million |
| Allergy and Infectious Diseases Research | 2 | $655,000 |
| Cardiovascular Diseases Research | 1 | $300,000 |
| Arthritis, Musculoskeletal and Skin Diseases Research | 1 | $295,294 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 7 | $2.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A novel lentivector for enhanced in vivo delivery of t cell receptors for cell therapy for stage IV melanoma - project summary project title: a novel lentivector for enhanced in vivo delivery of t cell receptors for cell therapy for stage IV melanoma organization: gigamune inc. Pi: david scott johns | Cancer Treatment Research | September 12, 2025 | $400,000 |
| Engineered tcr-t cell therapies targeting shared tumor associated antigens - project summary project title: engineered tcr-t cell therapies targeting shared tumor associated antigens organization: gigamune inc. Pi: matthew j spindler, ph.d. Adoptive cell therapies (ACTS) including car-t, tcr-t, and | Cancer Treatment Research | July 22, 2021 | $400,000 |
| Engineered tcr-t cell therapy targeting driver mutations in nsclc - project summary project title: engineered tcr-t cell therapy targeting driver mutations in nsclc organization: gigamune inc. Pi: matthew j spindler, ph.d. Adoptive cell therapies (ACTS) including car-t, tcr-t, and til therapies have | Cancer Treatment Research | April 28, 2021 | $400,000 |
| Engineered tcr-treg cell therapies targeting type 1 diabetes autoantigens - project summary project title: engineered tcr-treg cell therapies targeting type 1 diabetes autoantigens organization: gigamune inc. Pi: matthew j spindler, ph.d. Engineered adoptive cell therapies including car-t and tcr-t | Allergy and Infectious Diseases Research | August 11, 2022 | $355,000 |
| In vivo sickle cell disease gene therapy using a novel virus like particle - project summary project title: in vivo sickle cell disease gene therapy using a novel virus like particle organization: gigamune, inc. Pi: david s. Johnson, ph.d. Β-hemoglobinopathies are the most common monogenic disorders | Cardiovascular Diseases Research | September 5, 2024 | $300,000 |
| In vivo gene delivery to regulatory t cells to drastically reduce the cost of regulatory t cell therapy - project summary project title: in vivo gene delivery to regulatory t cells to drastically reduce the cost of regulatory t cell therapy organization: gigamune inc. Pi: david johnson, ph.d. Over 9 | Allergy and Infectious Diseases Research | April 19, 2023 | $300,000 |
| Delivery of full length dystrophin to muscle cells for dmd gene therapy - project summary project title: delivery of full length dystrophin to muscle cells for dmd gene therapy organization: gigamune inc. Pi: david johnson, ph.d. Duchenne’s muscular dystrophy (DMD) is a severe, incurable, x-linked r | Arthritis, Musculoskeletal and Skin Diseases Research | August 22, 2023 | $295,294 |
Questions people ask
How much federal grant money does Gigamune, Inc. get?
$2.5 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Gigamune, Inc. the most?
The Department of Health and Human Services, with $2.5 million in 7 awards.
What is Gigamune, Inc.'s largest federal grant?
$400,000 under Cancer Treatment Research, with its first action in the period on September 12, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Gigamune, Inc.?
Its largest are Cancer Treatment Research, Allergy and Infectious Diseases Research and Cardiovascular Diseases Research.
Other grant recipients in San Francisco
- The Regents of the University of California, San Francisco
- California Public Utilities Commission
- City & County of San Francisco
- City & County of San Francisco
- Golden Gate Bridge, Highway & Transportation District
- City and County of San Francisco
- Wested
- San Francisco State University
Largest federal grant recipients in California · Federal grants in California